U.S. Food & Drug Administration
Antimicrobial resistance is common in Shiga toxin-producing E. coli
Published in Medicine and Law Weekly, December 9th, 2005
"The objective of this study was to identify antimicrobial resistance and class 1 integrons among Shiga toxin-producing Escherichia coli (STEC). Two-hundred and seventy-four STEC recovered from poultry, cattle, swine and humans were characterized by antimicrobial susceptibility testing, screened for the presence of class 1 integrons by PCR, and assayed for integron transfer by conjugation," researchers in the United States report.
"Ninety-three (34%) of the isolates were resistant to streptomycin, followed by 89 (32%) to sulfamethoxazole, 83 (30%) to...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
More Articles from Medicine and Law Weekly
- Aarhus University Hospital
Ethical and practical problems exist in blood sampling for research during emergencies - AstraZeneca Pharmaceuticals, L.P.
Pulmicort Respules well-tolerated in children with severe asthma - Boston Scientific Corp.
New Medicare reimbursement codes approved for rechargeable neurostimulators - Competitive Technologies, Inc.
U.S. Supreme Court agrees to hear appeal on homocysteine patentability issue - Cord Blood Registry
Newborn stem cell bank announces settlement of litigation with Viacord - Cyberonics, Inc.
Medicare outpatient reimbursement rates for 2006 for VNS therapy posted - More from this issue of Medicine and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
